MIG (CXCL9) Bovine Recombinant
Recombinant Bovine MIG (CXCL9), produced in E. coli, is a non-glycosylated polypeptide chain composed of 104 amino acids. With a molecular weight of approximately 18.0 kDa, MIG undergoes purification using proprietary chromatographic techniques.
Escherichia Coli.
Sterile Filtered White lyophilized (freeze-dried) powder.
MIG Human Recombinant (CXCL9)
Recombinant Human MIG, produced in E. coli, is a single, non-glycosylated polypeptide chain. It consists of 103 amino acids, resulting in a molecular weight of 11.7 kDa. The purification process involves proprietary chromatographic techniques to ensure high purity.
MIG Human Recombinant (CXCL9), His Tag
MIG Mouse Recombinant (CXCL9)
Key Biological Properties: CXCL9 is known for its cytokine activity, chemokine receptor binding, and protein binding capabilities . It is involved in various biological processes, including chemotaxis, immune response, and inflammatory response .
Expression Patterns: CXCL9 is expressed in various tissues, including the appendix, lymph nodes, nasal mucosa, and testicles . It is also found in subcutaneous adipose tissue, mesenteric lymph nodes, and the spleen .
Tissue Distribution: The expression of CXCL9 is widespread, with significant levels in the lymphoid tissues and other organs involved in immune responses .
Primary Biological Functions: CXCL9 plays a pivotal role in inducing chemotaxis, promoting the differentiation and multiplication of leukocytes, and causing tissue extravasation . It is essential for the recruitment of immune cells such as cytotoxic lymphocytes, natural killer cells, and macrophages .
Role in Immune Responses: CXCL9 is involved in the recruitment and activation of immune cells, contributing to the body’s defense against pathogens . It also plays a role in Th1 polarization, which activates immune cells in response to interferon-gamma (IFN-γ) .
Pathogen Recognition: CXCL9 is involved in the immune response to various pathogens, including bacteria and viruses .
Mechanisms with Other Molecules and Cells: CXCL9 interacts with its receptor CXCR3 to regulate immune cell migration, differentiation, and activation . This interaction is crucial for the recruitment of immune cells to sites of inflammation or infection .
Binding Partners: CXCL9 primarily binds to the CXCR3 receptor, which is expressed on various immune cells .
Downstream Signaling Cascades: The binding of CXCL9 to CXCR3 activates downstream signaling pathways, including the G protein-coupled receptor signaling pathway and the chemokine-mediated signaling pathway .
Biomedical Research: CXCL9 is extensively studied in the context of immune responses and inflammatory diseases . It is also investigated for its role in cancer and other pathological conditions .
Diagnostic Tools: CXCL9 can serve as a biomarker for various diseases, including cancers and inflammatory conditions .
Therapeutic Strategies: Targeting the CXCL9/CXCR3 axis is being explored as a potential therapeutic strategy for enhancing immune responses and treating cancers .
Development: CXCL9 plays a role in the development of the immune system by regulating the migration and differentiation of immune cells .
Aging: The expression and activity of CXCL9 can change with age, potentially affecting immune responses in older individuals .
Disease: CXCL9 is involved in various diseases, including cancers, inflammatory conditions, and infectious diseases . Its role in these diseases makes it a potential target for therapeutic interventions .